The key advantage of our advanced disease models lies in their direct derivation from tumor biopsies, enabling physiological relevance.
If you need a patient-derived model but do not have access to biopsy tissue for your specific indication, we can source the necessary samples on your behalf, saving you valuable time and effort.
The Sources of our Tumor Samples
Our 3D-bioprinted tumors are directly derived from donated tumor tissue. We store this tissue in our own facility or source it on your behalf.
Carcinotech’s Tumor Tissue Bank
We have fresh-frozen biopsies for common cancers available in our facility and are constantly adding more.
This readily-available supply allows our partners to start their investigational projects in as little as 14 days.
Our Biopsy Sourcing Service
We alleviate the burden on our clients by sourcing a variety of cancer samples on their behalf, saving them valuable time.
Through our partnerships with UK and European biobanks, we can source additional cancer types beyond our existing supply.
Tumor Tissue Available in our Repository
Lung
Brain
Breast
Colorectal
Pancreatic
Ovarian
Lung
Brain
Pancreatic
Lung
Brain
Pancreatic
Lung
Brain
Pancreatic
Gain Insights with Comprehensive Characterization Data
We conduct extensive characterization assays on each biopsy and provide anonymized clinical data, facilitating a comprehensive understanding of the patient profile. This information supports pre-selection for your R&D studies, planning for future clinical trials, and identification of novel biomarkers.
This information supports pre-selection for your R&D studies, stratification for future clinical trials, and identification of novel biomarkers.
Genetic
Phenotypic
Molecular
Clinical
Benefit from the Addition of Patient-matched PBMCs
In addition to tumor biopsies, we can collect and store patient-derived peripheral blood mononuclear cells (PBMCs). These cells can complement tissue-derived immune components, providing a robust platform for immunotherapy studies.
Monocyte
Macrophage
Cancer Associated Fibroblast
Peripheral Blood Mononuclear Cell
Cancer Stem Cell
Cancer Cell
T-cell
B-cell
Natural Killer cell
Endothelial cell
Extracellular Matrix
Carcino3DTM Tumor with Patient-matched PBMCs
Banked for Future Studies
If you need to conduct confirmatory and follow-up testing after your initial project, we can ensure that a portion of the original biopsy is cryopreserved and readily available for retrieval.
Frequently Asked Questions
Yes, our biopsies are ethically sourced from patients who have given informed consent.
We would recommend 2-3 different patient-derived samples for an initial study to enhance the validity, reliability, and applicability of research findings. We can generate up to 400 3D-bioprinted tumors from a single patient biopsy.
Yes, we can utilize your tumor biopsies. We will work with you to ensure their safe shipment from your facility to ours. Upon receipt, we will follow our standard protocols to produce a 3D-bioprinted tumor.
We isolate the cells from the tumor tissue using a custom dissociation process. This step ensures we capture the full range of cells within the tumor, creating a heterogeneous population that mirrors the complexity of real tumors.
We cryopreserve the dissociated cells in our facility to ensure their viability and long-term storage.
